Royal Bank of Canada »

Unicycive Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 377 0.00

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Unicycive Therapeutics

Vivo Capital
Millennium Management
Octagon Capital Advisors
Nantahala Capital Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Susquehanna International
Logos Global Management
Citadel Advisors
Integral Health Asset Management
Geode Capital Management
Morgan Stanley
Jane Street
Marshall Wace

View all funds holding Unicycive Therapeutics